carbostyril has been researched along with Cushing's Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galac, S; Kooistra, HS; Mol, JA; Sanders, K; Slob, A | 1 |
| Hartmann, RW; Hu, Q; Kazmaier, U; Lucas, S; Maurer, F; Yin, L | 1 |
| Daidoh, H; Hanafusa, J; Ishizuka, T; Morita, H; Mune, T; Murase, H; Sato, M; Shibata, T; Suwa, T; Yasuda, K | 1 |
3 other study(ies) available for carbostyril and Cushing's Syndrome
| Article | Year |
|---|---|
Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Animals; Cell Line, Tumor; Cell Survival; Cushing Syndrome; DNA; Dog Diseases; Dogs; Female; Hydrocortisone; Male; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Steroidogenic Factor 1 | 2018 |
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.
Topics: Animals; Aromatase; Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Quinolones; Rats; Stereoisomerism; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Substrate Specificity | 2012 |
In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Cells, Cultured; Cushing Syndrome; Diuretics; Drug Administration Schedule; Furosemide; Gastric Inhibitory Polypeptide; Humans; Hydrocortisone; Hyperplasia; Injections, Intravenous; Insulin; Male; Middle Aged; Piperidines; Posture; Quinolones | 1998 |